Age at Menopause and Dementia Risk: Blood-Based Biomarker Evidence from a US National Study
Importance: Earlier age at menopause associates with increased later life dementia risk, but the biological links that underlie this relationship remain poorly understood in population-based samples. Objective: To evaluate the relationship between history of menopausal timing and AD/ADRD-related blood-based biomarkers in postmenopausal women. Design: Observational study using the U.S. Health and Retirement Study. AD/ADRD-related biomarkers were measured from venous blood draws conducted in 2016 and released in 2025. We estimated linear and nonlinear associations between spontaneous menopause timing and biomarkers, accounting for sociodemographic and health covariates. We evaluated effect modification by APOE ɛ4 carrier status. Secondary analyses evaluated associations with hysterectomy history. Setting: Population-based. Participants: Community-dwelling post-menopausal women aged 65 years or older. Exposure: Primary: Self-reported spontaneous age of menopause among women with no history of hysterectomy. Secondary: Self-reported history of hysterectomy (oophorectomy history was not assessed). Main Outcomes and Measures: Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) measured in plasma, and phosphorylated tau (p-tau181) and growth differentiation factor 15 (GDF-15), measured in serum, by Simoa or ELLA. Results: Among 1449 women ≥65 years, 38.4% self-reported a hysterectomy. Among 893 postmenopausal women without a history of hysterectomy (mean [SD] age at biomarker collection, 75.2 [7.2] years; mean age at menopause, 50.2 [5.2] years), menopausal timing was nonlinearly associated with NfL. Between menopausal ages 45-50, menopause timing was associated with higher NfL (0.010 SD units/year, [95% CI: -0.007, 0.027]), while from menopausal ages 50-55, the association reversed (b= -0.031, [95% CI: -0.051, -0.011]). Associations with GFAP or pTau-181 were not significant, but were directionally similar to those observed for NfL. Later menopausal timing linearly associated with lower GDF-15 (b = -0.015, [95% CI: -0.027, -0.004]). Self-reported hysterectomy was associated with higher GDF-15 (b= 0.118, [95% CI: 0.015, 0.220]), but not other biomarkers. Associations did not significantly differ by APOE ϵ4 status. Conclusions and Relevance: In a nationally representative study, earlier age at menopause in midlife was associated with later life AD/ADRDs biomarkers reflecting neuroaxonal degeneration and inflammation, underscoring the importance of understanding reproductive aging in dementia risk.
Authors
- Muqi Guo (ORCID: https://orcid.org/0000-0001-7081-5158)
- Sadaf Arefi Milani (ORCID: https://orcid.org/0000-0001-6631-6532)
- Kaitlin Blackstone Casaletto (ORCID: https://orcid.org/0000-0001-5000-7604)
- Michelle R. Caunca (ORCID: https://orcid.org/0000-0002-5177-9048)
- Jacqueline M. Torres (ORCID: https://orcid.org/0000-0002-1579-6107)
- Eleanor Hayes‐Larson (ORCID: https://orcid.org/0000-0001-8299-2389)
- Sirena Gutierrez (ORCID: https://orcid.org/0000-0001-9201-698X)
- Paola Gilsanz (ORCID: https://orcid.org/0000-0002-7635-381X)
Institutions
- University of Southern California (US)
- University of California, San Francisco (US)
- University of Michigan (US)
- Kaiser Permanente Northern California (US)
- The University of Texas Medical Branch at Galveston (US)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-15
- DOI
- https://doi.org/10.64898/2026.11.12.26367954
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- preprint